This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alvarez, M.
Right arrow Articles by Jacoby, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alvarez, M.
Right arrow Articles by Jacoby, G. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2004, p. 533-537, Vol. 48, No. 2
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.2.533-537.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Epidemiology of Conjugative Plasmid-Mediated AmpC ß-Lactamases in the United States

M. Alvarez,{dagger} J. H. Tran, N. Chow, and G. A. Jacoby*

Lahey Clinic, Burlington, and Edith Nourse Rogers Memorial Veterans Hospital, Bedford, Massachusetts

Received 24 July 2003/ Returned for modification 30 September 2003/ Accepted 13 October 2003

A sample of 752 resistant Klebsiella pneumoniae, Klebsiella oxytoca, and Escherichia coli strains from 70 sites in 25 U.S. states and the District of Columbia was examined for transmissibility of resistance to ceftazidime and the nature of the plasmid-mediated ß-lactamase involved. Fifty-nine percent of the K. pneumoniae, 24% of the K. oxytoca, and 44% of the E. coli isolates transferred resistance to ceftazidime. Plasmids encoding AmpC-type ß-lactamase were found in 8.5% of the K. pneumoniae samples, 6.9% of the K. oxytoca samples, and 4% of the E. coli samples, at 20 of the 70 sites and in 10 of the 25 states. ACT-1 ß-lactamase was found at eight sites, four of which were near New York City, where the ACT-1 enzyme was first discovered; ACT-1 ß-lactamase was also found in Massachusetts, Pennsylvania, and Virginia. FOX-5 ß-lactamase was also found at eight sites, mainly in southeastern states but also in New York. Two E. coli strains produced CMY-2, and one K. pneumoniae strain produced DHA-1 ß-lactamase. Pulsed-field gel electrophoresis and plasmid analysis suggested that AmpC-mediated resistance spread both by strain and plasmid dissemination. All AmpC ß-lactamase-containing isolates were resistant to cefoxitin, but so were 11% of strains containing transmissible SHV- and TEM-type extended-spectrum ß-lactamases. A ß-lactamase inhibitor test was helpful in distinguishing the two types of resistance but was not definitive since 24% of clinical isolates producing AmpC ß-lactamase had a positive response to clavulanic acid. Coexistence of AmpC and extended-spectrum ß-lactamases was the main reason for these discrepancies. Plasmid-mediated AmpC-type enzymes are thus responsible for an appreciable fraction of resistance in clinical isolates of Klebsiella spp. and E. coli, are disseminated around the United States, and are not so easily distinguished from other enzymes that mediate resistance to oxyimino-ß-lactams.

* Corresponding author. Mailing address: Lahey Clinic, 41 Mall Rd., Burlington, MA 01805. Phone: (781) 744-2928. Fax: (781) 744-5486. E-mail: george.a.jacoby{at}lahey.org.

{dagger} Present address: Clinical Microbiology Laboratory, Complejo Hospitalario Universitario Xeral-Cíes de Vigo, 36204-Vigo, Pontevedra, Spain.

Antimicrobial Agents and Chemotherapy, February 2004, p. 533-537, Vol. 48, No. 2
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.2.533-537.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Paukner, S., Hesse, L., Prezelj, A., Solmajer, T., Urleb, U. (2009). In Vitro Activity of LK-157, a Novel Tricyclic Carbapenem As Broad-Spectrum {beta}-Lactamase Inhibitor. Antimicrob. Agents Chemother. 53: 505-511 [Abstract] [Full Text]  
  • Jacoby, G. A. (2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev. 22: 161-182 [Abstract] [Full Text]  
  • Zhu, L.-X., Zhang, Z.-W., Liang, D., Jiang, D., Wang, C., Du, N., Zhang, Q., Mitchelson, K., Cheng, J. (2007). Multiplex Asymmetric PCR-Based Oligonucleotide Microarray for Detection of Drug Resistance Genes Containing Single Mutations in Enterobacteriaceae. Antimicrob. Agents Chemother. 51: 3707-3713 [Abstract] [Full Text]  
  • Queenan, A. M., Shang, W., Kania, M., Page, M. G. P., Bush, K. (2007). Interactions of Ceftobiprole with {beta}-Lactamases from Molecular Classes A to D. Antimicrob. Agents Chemother. 51: 3089-3095 [Abstract] [Full Text]  
  • Yang, K., Guglielmo, B J. (2007). Diagnosis and Treatment of Extended-Spectrum and AmpC {beta}-Lactamase-Producing Organisms. The Annals of Pharmacotherapy 41: 1427-1435 [Abstract] [Full Text]  
  • Chen, Y.-T., Lauderdale, T.-L., Liao, T.-L., Shiau, Y.-R., Shu, H.-Y., Wu, K.-M., Yan, J.-J., Su, I.-J., Tsai, S.-F. (2007). Sequencing and Comparative Genomic Analysis of pK29, a 269-Kilobase Conjugative Plasmid Encoding CMY-8 and CTX-M-3 {beta}-Lactamases in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 51: 3004-3007 [Abstract] [Full Text]  
  • Moland, E. S., Hanson, N. D., Black, J. A., Hossain, A., Song, W., Thomson, K. S. (2006). Prevalence of Newer {beta}-Lactamases in Gram-Negative Clinical Isolates Collected in the United States from 2001 to 2002.. J. Clin. Microbiol. 44: 3318-3324 [Abstract] [Full Text]  
  • Padilla, E., Alonso, D., Domenech-Sanchez, A., Gomez, C., Perez, J. L., Alberti, S., Borrell, N. (2006). Effect of Porins and Plasmid-Mediated AmpC {beta}-Lactamases on the Efficacy of {beta}-Lactams in Rat Pneumonia Caused by Klebsiella pneumoniae.. Antimicrob. Agents Chemother. 50: 2258-2260 [Abstract] [Full Text]  
  • Jacoby, G. A., Walsh, K. E., Walker, V. J. (2006). Identification of Extended-Spectrum, AmpC, and Carbapenem- Hydrolyzing {beta}-Lactamases in Escherichia coli and Klebsiella pneumoniae by Disk Tests.. J. Clin. Microbiol. 44: 1971-1976 [Abstract] [Full Text]  
  • Power, P., Galleni, M., Ayala, J. A., Gutkind, G. (2006). Biochemical and Molecular Characterization of Three New Variants of AmpC {beta}-Lactamases from Morganella morganii. Antimicrob. Agents Chemother. 50: 962-967 [Abstract] [Full Text]  
  • Verdet, C., Benzerara, Y., Gautier, V., Adam, O., Ould-Hocine, Z., Arlet, G. (2006). Emergence of DHA-1-Producing Klebsiella spp. in the Parisian Region: Genetic Organization of the ampC and ampR Genes Originating from Morganella morganii. Antimicrob. Agents Chemother. 50: 607-617 [Abstract] [Full Text]  
  • D'Andrea, M. M., Nucleo, E., Luzzaro, F., Giani, T., Migliavacca, R., Vailati, F., Kroumova, V., Pagani, L., Rossolini, G. M. (2006). CMY-16, a Novel Acquired AmpC-Type {beta}-Lactamase of the CMY/LAT Lineage in Multifocal Monophyletic Isolates of Proteus mirabilis from Northern Italy. Antimicrob. Agents Chemother. 50: 618-624 [Abstract] [Full Text]  
  • Song, W., Moland, E. S., Hanson, N. D., Lewis, J. S., Jorgensen, J. H., Thomson, K. S. (2005). Failure of Cefepime Therapy in Treatment of Klebsiella pneumoniae Bacteremia. J. Clin. Microbiol. 43: 4891-4894 [Abstract] [Full Text]  
  • Pichardo, C., Rodriguez-Martinez, J. M., Pachon-Ibanez, M. E., Conejo, C., Ibanez-Martinez, J., Martinez-Martinez, L., Pachon, J., Pascual, A. (2005). Efficacy of Cefepime and Imipenem in Experimental Murine Pneumonia Caused by Porin-Deficient Klebsiella pneumoniae Producing CMY-2 {beta}-Lactamase. Antimicrob. Agents Chemother. 49: 3311-3316 [Abstract] [Full Text]  
  • Black, J. A., Moland, E. S., Thomson, K. S. (2005). AmpC Disk Test for Detection of Plasmid-Mediated AmpC {beta}-Lactamases in Enterobacteriaceae Lacking Chromosomal AmpC {beta}-Lactamases. J. Clin. Microbiol. 43: 3110-3113 [Abstract] [Full Text]  
  • Mulvey, M. R., Bryce, E., Boyd, D. A., Ofner-Agostini, M., Land, A. M., Simor, A. E., Paton, S., the Canadian Hospital Epidemiology Committee, , the Canadian Nosocomial Infection Surveillance Pro, (2005). Molecular Characterization of Cefoxitin-Resistant Escherichia coli from Canadian Hospitals. Antimicrob. Agents Chemother. 49: 358-365 [Abstract] [Full Text]  
  • Literacka, E., Empel, J., Baraniak, A., Sadowy, E., Hryniewicz, W., Gniadkowski, M. (2004). Four Variants of the Citrobacter freundii AmpC-Type Cephalosporinases, Including Novel Enzymes CMY-14 and CMY-15, in a Proteus mirabilis Clone Widespread in Poland. Antimicrob. Agents Chemother. 48: 4136-4143 [Abstract] [Full Text]  
  • Liebana, E., Batchelor, M., Clifton-Hadley, F. A., Davies, R. H., Hopkins, K. L., Threlfall, E. J. (2004). First Report of Salmonella Isolates with the DHA-1 AmpC {beta}-Lactamase in the United Kingdom. Antimicrob. Agents Chemother. 48: 4492-4492 [Full Text]  
  • Jacoby, G. A., Mills, D. M., Chow, N. (2004). Role of {beta}-Lactamases and Porins in Resistance to Ertapenem and Other {beta}-Lactams in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48: 3203-3206 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»